SCHEMBL31166954

SCHEMBL31166954

Fc1ccc(OCc2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.58
▸ LMNA P02545 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ PTGS1 P23219 1/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ PTGS2 P35354 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ MAOB P27338 9/20 0.50
▸ MAOA P21397 3/20 0.50
▸ GAA P10253 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CTSV O60911 1/20 0.49
▸ CTSL P07711 1/20 0.49
▸ TOP1 P11387 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15365 0.88 MAOB (0.58) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL27771711 0.88 MAOB (0.58) MAOBGAAMAPTRAB9ASMN1; SMN2
SCHEMBL16034065 0.87 ALOX5 (0.44) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL28397428 0.86 KAT6A (0.47) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL28396058 0.86 ALOX5 (0.47) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL15817 0.85 ALOX5 (0.61) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL31464123 0.84 ALOX5 (0.49) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL13412635 0.83 ALOX5 (0.63) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL28399722 0.82 LMNA (0.52) ALOX5LMNACYP1A2PTGS1SLC6A2
SCHEMBL29704022 0.81 KDM1A (0.55) MAOBRAB9ASMN1; SMN2MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698520-A1 RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF Gandeeva Therapeutics, Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220708-A1 RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF GANDEEVA THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
Send feedback